TY - JOUR
T1 - Developments in transcatheter tricuspid valve therapies
AU - Voci, Davide
AU - Pozzoli, Alberto
AU - Miura, Mizuki
AU - Gavazzoni, Mara
AU - Gülmez, Gökhan
AU - Scianna, Salvatore
AU - Zuber, Michel
AU - Maisano, Francesco
AU - Taramasso, Maurizio
N1 - Publisher Copyright:
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2019/12/2
Y1 - 2019/12/2
N2 - Introduction: Transcatheter tricuspid valve (TV) procedures emerged as an alternative to surgery for symptomatic high-risk patients with severe tricuspid regurgitation. Areas covered: A literature search was performed using PubMed. Authors review clinical evidence in this field, the imaging features and the developments in TV transcatheter technologies. Currently, transcatheter devices for TV procedures can be allocated into four main groups: 1) those ones targeting leaflet malcoaptation, 2) those addressing annular dilatation, 3) those performing heterotopic valve implantation and 4) those onesaccomplishing a complete transcatheter replacement of the valve. Expert opinion: Actually, encouraging results are provided by initial experience in the field of transcatheter TV procedures. However, this field remains full of challenges that faced could lead to better results and prognosis for the patients. The next steps in this emerging field will need to focus on accurate patient selection, an early patient referral and on studies comparable and providing long-term data.
AB - Introduction: Transcatheter tricuspid valve (TV) procedures emerged as an alternative to surgery for symptomatic high-risk patients with severe tricuspid regurgitation. Areas covered: A literature search was performed using PubMed. Authors review clinical evidence in this field, the imaging features and the developments in TV transcatheter technologies. Currently, transcatheter devices for TV procedures can be allocated into four main groups: 1) those ones targeting leaflet malcoaptation, 2) those addressing annular dilatation, 3) those performing heterotopic valve implantation and 4) those onesaccomplishing a complete transcatheter replacement of the valve. Expert opinion: Actually, encouraging results are provided by initial experience in the field of transcatheter TV procedures. However, this field remains full of challenges that faced could lead to better results and prognosis for the patients. The next steps in this emerging field will need to focus on accurate patient selection, an early patient referral and on studies comparable and providing long-term data.
KW - transcatheter tricuspid valve therapy
KW - Transcatheter tricuspid valve treatment
KW - tricuspid regurgitation
KW - tricuspid valve
KW - valvular heart disease
UR - https://www.scopus.com/pages/publications/85076343081
U2 - 10.1080/14779072.2019.1699056
DO - 10.1080/14779072.2019.1699056
M3 - 総説
C2 - 31795771
AN - SCOPUS:85076343081
SN - 1477-9072
VL - 17
SP - 841
EP - 856
JO - Expert Review of Cardiovascular Therapy
JF - Expert Review of Cardiovascular Therapy
IS - 12
ER -